1. Home
  2. VVOS vs APM Comparison

VVOS vs APM Comparison

Compare VVOS & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • APM
  • Stock Information
  • Founded
  • VVOS 2016
  • APM 2010
  • Country
  • VVOS United States
  • APM United Kingdom
  • Employees
  • VVOS N/A
  • APM N/A
  • Industry
  • VVOS Medical Specialities
  • APM Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVOS Health Care
  • APM Health Care
  • Exchange
  • VVOS Nasdaq
  • APM Nasdaq
  • Market Cap
  • VVOS 19.4M
  • APM 18.9M
  • IPO Year
  • VVOS 2020
  • APM 2018
  • Fundamental
  • Price
  • VVOS $2.43
  • APM $1.40
  • Analyst Decision
  • VVOS Strong Buy
  • APM
  • Analyst Count
  • VVOS 2
  • APM 0
  • Target Price
  • VVOS $6.25
  • APM N/A
  • AVG Volume (30 Days)
  • VVOS 246.5K
  • APM 207.8K
  • Earning Date
  • VVOS 11-17-2025
  • APM 12-19-2025
  • Dividend Yield
  • VVOS N/A
  • APM N/A
  • EPS Growth
  • VVOS N/A
  • APM N/A
  • EPS
  • VVOS N/A
  • APM N/A
  • Revenue
  • VVOS $14,393,000.00
  • APM N/A
  • Revenue This Year
  • VVOS $19.45
  • APM N/A
  • Revenue Next Year
  • VVOS $70.80
  • APM N/A
  • P/E Ratio
  • VVOS N/A
  • APM N/A
  • Revenue Growth
  • VVOS 2.65
  • APM N/A
  • 52 Week Low
  • VVOS $1.98
  • APM $0.46
  • 52 Week High
  • VVOS $7.95
  • APM $7.49
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 32.97
  • APM 37.80
  • Support Level
  • VVOS $2.35
  • APM $1.43
  • Resistance Level
  • VVOS $2.88
  • APM $1.50
  • Average True Range (ATR)
  • VVOS 0.21
  • APM 0.09
  • MACD
  • VVOS -0.02
  • APM -0.01
  • Stochastic Oscillator
  • VVOS 10.81
  • APM 9.87

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: